Intrapleural bortezomib for the therapy of myelomatous pleural effusion: a case report.
Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed good local response, the patient succumbed due to systemic myeloma progression.
1st Department of Medicine and Clinical Department of Hematology, the General Teaching Hospital, Charles University in Prague, Prague, Czech Republic ; Institute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Magdalena
M
Klanova
1st Department of Medicine and Clinical Department of Hematology, the General Teaching Hospital, Charles University in Prague, Prague, Czech Republic ; Institute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Pavel
P
Klener
1st Department of Medicine and Clinical Department of Hematology, the General Teaching Hospital, Charles University in Prague, Prague, Czech Republic ; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
Marek
M
Trneny
1st Department of Medicine and Clinical Department of Hematology, the General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
Jan
J
Straub
1st Department of Medicine and Clinical Department of Hematology, the General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
Ivan
I
Spicka